Tyrogenex Inc

Tyrogenex, Inc. operates as a biopharmaceutical company. The Company focuses on developing dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors.